Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KRAS | P01116 | 13/20 | 0.47 |
| ▸ | SMARCA2 | P51531 | 1/20 | 0.34 |
| ▸ | SMARCA4 | P51532 | 1/20 | 0.34 |
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.34 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.32 |
| ▸ | NSD2 | O96028 | 1/20 | 0.32 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.31 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21137354 | 0.89 | KRAS (0.59) | KRAS | |
| SCHEMBL21100029 | 0.85 | KRAS (0.64) | KRAS | |
| SCHEMBL21136850 | 0.81 | KRAS (0.40) | KRAS | |
| SCHEMBL21050816 | 0.75 | KRAS (0.69) | KRAS | |
| SCHEMBL21050727 | 0.75 | KRAS (0.81) | KRAS | |
| SCHEMBL21099360 | 0.75 | KRAS (0.79) | KRAS | |
| SCHEMBL21099996 | 0.75 | KRAS (0.79) | KRAS | |
| SCHEMBL21099259 | 0.73 | KRAS (0.45) | KRASGPR119USP30 | |
| SCHEMBL21099260 | 0.73 | KRAS (0.46) | KRASGPR119USP30 | |
| SCHEMBL21099228 | 0.72 | KRAS (0.49) | KRASSMARCA2SMARCA4PBRM1GPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019110751-A1 | TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS | ASTRAZENECA AB (SE) | 2019-06-13 | — | — | WO | disclosed |